Envoy Medical has reached the six-month follow-up milestone in its pivotal U.S. trial for the fully implanted Acclaim® cochlear implant, marking the halfway point in data collection. The company aims to complete 12-month visits by early Q2 2027 and submit final clinical data to the FDA by the end of that quarter. This device is unique as it requires no external components and uses a natural ear sensor to capture sound. Envoy Medical expects potential FDA approval by late 2027 or early 2028, offering a new option for people with severe hearing loss.
Envoy Medical's pivotal U.S. trial for its fully implanted Acclaim® cochlear implant has reached the six-month follow-up milestone, marking the halfway point in data collection. For readers following the health sector, here is Pluang's market snapshot as of Oct 20, 2026 19:03 WIB: out of 150 priced health-sector US stocks, 81 rose and 62 fell today. Notable movers include Sanofi SA (SNY) at USD 40.57 with a 1-day change of +2.53% and a typical hold time of 95 days, Crispr Therapeutics AG (CRSP) at USD 48.95 with a 1-day change of -2.18% and Pluang order activity showing 17% sell / 83% buy, and Elanco Animal Health Incorporated (ELAN) at USD 22.99 with a 1-day change of -2.13% and a typical hold time of 11 days.
Hershey is preparing to announce its Q3 earnings on October 29, with analysts forecasting earnings per share (EPS) of $2.12, a 63% increase from last year, and revenue of $3.25 billion, up 2.3%. The company has shown strong recent performance, with Q...
3M reported strong Q3 2026 earnings with adjusted EPS of $2.50, beating estimates of $2.38, and GAAP profit rising to $1.37 billion from $834 million a year earlier. Sales reached $6.6 billion, slightly below estimates, but showed 3.3% organic growth...
Alaska Air Group is set to report Q3 2026 earnings with analysts expecting a 66.7% drop in earnings per share to $0.35, despite a 14.5% increase in revenue to $4.31 billion driven by strong travel demand. Passenger revenue is forecast to rise 10.2%, ...
Baba, an applied AI company focused on modernizing Medicare and Medicaid care, has raised $40 million in a Series A funding round led by FirstMark Capital, with participation from CVS Health Ventures and others. The funding will help Baba expand its ...
Richard Campbell-Breeden, a seasoned investment banker with 37 years of experience including 27 years at Goldman Sachs, has joined SEDA Experts LLC as Managing Director. His expertise in mergers and acquisitions, corporate finance, and governance wil...
